Skip to main navigation Skip to search Skip to main content

Patent pools and clearinghouses in the life sciences

  • Esther Van Zimmeren
  • , Sven Vanneste
  • , Gert Matthijs
  • , Wim Vanhaverbeke
  • , Geertrui Van Overwalle

Research output: Indexed journal article Articlepeer-review

29 Citations (Scopus)

Abstract

The biopharmaceutical industry is slowly absorbing the idea of collaborative patent licensing models. Recently, two patent pools for developing countries have been launched: the Pool for Open Innovation against Neglected Tropical Diseases initiated by GlaxoSmithKline (GSK), which is referred to as the BIO Ventures for Global Health (BVGH) pool, and the Medicines Patent Pool (MPP) initiated by UNITAID. Various organizations have recommended using pools or clearinghouses beyond the humanitarian dimension where many patents are owned by many different actors. As a first attempt, MPEG LA, which administers patent pools in various technology fields, is now setting up a clearinghouse for patents related to molecular diagnostics. These examples as well as the results from an empirical study provide useful insights for the design and administration of future pools and clearinghouses in the life sciences.
Original languageEnglish
Pages (from-to)569-576
JournalTrends in Biotechnology
Volume29
Issue number11
DOIs
Publication statusPublished - 1 Nov 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Patent pools and clearinghouses in the life sciences'. Together they form a unique fingerprint.

Cite this